Anticorps Polyclonal de lapin anti-RETNLB

RETNLB Polyclonal Antibody for IHC, Indirect ELISA

Hôte / Isotype

Lapin / IgG

Réactivité testée

Humain

Applications

IHC, Indirect ELISA

Conjugaison

Non conjugué

N° de cat : 18232-1-PBS

Synonymes

---

Galerie de données de validation

• 

  IHC staining of human small intestine using 18232-1-AP (same clone as 18232-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human small intestine tissue slide using 18232-1-AP (RETNLB antibody) at dilution of 1:200 (under 10x lens). This data was developed using the same antibody clone with 18232-1-PBS in a different storage buffer formulation.

• 

  IHC staining of human small intestine using 18232-1-AP (same clone as 18232-1-PBS)

  Immunohistochemical analysis of paraffin-embedded human small intestine tissue slide using 18232-1-AP (RETNLB antibody) at dilution of 1:200 (under 40x lens). This data was developed using the same antibody clone with 18232-1-PBS in a different storage buffer formulation.

---

Informations sur le produit

18232-1-PBS cible RETNLB dans les applications de IHC, Indirect ELISA et montre une réactivité avec des échantillons Humain

• Réactivité: Humain
• Hôte / Isotype: Lapin / IgG
• Clonalité: Polyclonal
• Type: Anticorps
• Immunogène: RETNLB Protéine recombinante Ag12912
• Nom complet: resistin like beta
• Masse moléculaire calculée: 111 aa, 12 kDa
• Numéro d’acquisition GenBank: BC069318
• Symbole du gène: RETNLB
• Identification du gène (NCBI): 84666
• Conjugaison: Non conjugué
• Forme: Liquide
• Méthode de purification: Purification par affinité contre l'antigène
• Tampon de stockage: PBS only
• Conditions de stockage: Store at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

RETNLB is an intestinal goblet cell-specific protein and is notably upregulated during intestinal inflammation. RETNLB also plays a role in several research areas, such as inflammatory disease, cancer, and metabolic function. In tumors, previous reports have suggested that positive expression of RETNLB was detected in most tissues from gastric carcinoma and colon cancer patients, RETNLB was also found involvement in oral squamous cell carcinoma [PMID: 34158059 19706296 27001185 15983036].

{{ptg:RelatedPrimaryAntibodies}}